142 related articles for article (PubMed ID: 7654828)
21. Epstein-Barr virus early ribonucleic acids as a diagnostic adjunct for relapsed metastatic tumors in patients with cured primary undifferentiated nasopharyngeal carcinoma.
Ho CL; Lee SH; Chen LM; Chao TY
Am J Otolaryngol; 2000; 21(2):80-4. PubMed ID: 10758991
[TBL] [Abstract][Full Text] [Related]
22. [Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy].
Hu Y; Lu T; Mai W; Han F; Huang Y; Liu H; Zhang E
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):463-7. PubMed ID: 12761966
[TBL] [Abstract][Full Text] [Related]
23. Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.
Li Y; Chen QY; Tang LQ; Liu LT; Guo SS; Guo L; Mo HY; Chen MY; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Shao JY; Sun Y; Tan J; Chen S; Ma J; Zhao C; Mai HQ
BMC Cancer; 2017 Aug; 17(1):567. PubMed ID: 28836950
[TBL] [Abstract][Full Text] [Related]
24. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy.
Bachouchi M; Cvitkovic E; Azli N; Gasmi J; Cortes-Funes H; Boussen H; Rahal M; Kalifa C; Schwaab G; Eschwege F
J Natl Cancer Inst; 1990 Apr; 82(7):616-20. PubMed ID: 1690306
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.
Huang J; Fogg M; Wirth LJ; Daley H; Ritz J; Posner MR; Wang FC; Lorch JH
Cancer; 2017 Jul; 123(14):2642-2650. PubMed ID: 28222215
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
Cao SM; Yang Q; Guo L; Mai HQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Qiu F; Sun R; Chen QY; Huang PY; Luo DH; Hua YJ; Wu YS; Lv X; Wang L; Xia WX; Tang LQ; Ye YF; Chen MY; Guo X; Hong MH
Eur J Cancer; 2017 Apr; 75():14-23. PubMed ID: 28214653
[TBL] [Abstract][Full Text] [Related]
28. Nasopharyngeal carcinoma.
Kamran SC; Riaz N; Lee N
Surg Oncol Clin N Am; 2015 Jul; 24(3):547-61. PubMed ID: 25979399
[TBL] [Abstract][Full Text] [Related]
29. Application of Epstein-Barr virus serology to the diagnosis and staging of North American patients with nasopharyngeal carcinoma.
Neel HB; Pearson GR; Weiland LH; Taylor WF; Goepfert HH; Pilch BZ; Goodman M; Lanier AP; Huang AT; Hyams VJ; Levine PH; Henle G; Henle W
Otolaryngol Head Neck Surg; 1983 Jun; 91(3):255-62. PubMed ID: 6308537
[TBL] [Abstract][Full Text] [Related]
30. Treatment approaches to nasopharyngeal carcinoma: a review.
Caponigro F; Longo F; Ionna F; Perri F
Anticancer Drugs; 2010 Jun; 21(5):471-7. PubMed ID: 20124988
[TBL] [Abstract][Full Text] [Related]
31. Nasopharyngeal carcinomas: an update.
Spano JP; Busson P; Atlan D; Bourhis J; Pignon JP; Esteban C; Armand JP
Eur J Cancer; 2003 Oct; 39(15):2121-35. PubMed ID: 14522369
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic evaluation of nasopharyngeal carcinoma: role of Epstein-Barr virus].
Plaza G; Fogué L; Martínez San Millán J; Martínez Vidal A; Bellas C
An Otorrinolaringol Ibero Am; 2002; 29(1):71-91. PubMed ID: 11962004
[TBL] [Abstract][Full Text] [Related]
33. Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma.
Pearson GR; Weiland LH; Neel HB; Taylor W; Earle J; Mulroney SE; Goepfert H; Lanier A; Talvot ML; Pilch B; Goodman M; Huang A; Levine PH; Hyams V; Moran E; Henle G; Henle W
Cancer; 1983 Jan; 51(2):260-8. PubMed ID: 6295597
[TBL] [Abstract][Full Text] [Related]
34. With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control study.
Liu LT; Chen QY; Tang LQ; Zhang L; Guo SS; Guo L; Mo HY; Zhao C; Guo X; Chen MY; Qian CN; Zeng MS; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
BMC Cancer; 2016 Oct; 16(1):774. PubMed ID: 27717335
[TBL] [Abstract][Full Text] [Related]
35. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
36. Nasopharyngeal carcinoma in the pediatric age group: the northern Israel (Rambam) medical center experience, 1989-2004.
Haimi M; Arush MW; Bar-Sela G; Gez E; Bernstein Z; Postovsky S; Barak AB; Kuten A
J Pediatr Hematol Oncol; 2005 Oct; 27(10):510-6. PubMed ID: 16217252
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in the treatment of nasopharyngeal carcinoma.
Chang JT; Ko JY; Hong RL
J Formos Med Assoc; 2004 Jul; 103(7):496-510. PubMed ID: 15318271
[TBL] [Abstract][Full Text] [Related]
38. Pediatric nasopharyngeal carcinoma: long term follow-up of 29 patients.
Pao WJ; Hustu HO; Douglass EC; Beckford NS; Kun LE
Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):299-305. PubMed ID: 2473970
[TBL] [Abstract][Full Text] [Related]
39. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
[TBL] [Abstract][Full Text] [Related]
40. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
